Bilemjian, V.; Vlaming, M.R.; Álvarez Freile, J.; Huls, G.; De Bruyn, M.; Bremer, E.
The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR Signaling. Cancers 2022, 14, 3164.
https://doi.org/10.3390/cancers14133164
AMA Style
Bilemjian V, Vlaming MR, Álvarez Freile J, Huls G, De Bruyn M, Bremer E.
The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR Signaling. Cancers. 2022; 14(13):3164.
https://doi.org/10.3390/cancers14133164
Chicago/Turabian Style
Bilemjian, Vrouyr, Martijn R. Vlaming, Jimena Álvarez Freile, Gerwin Huls, Marco De Bruyn, and Edwin Bremer.
2022. "The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR Signaling" Cancers 14, no. 13: 3164.
https://doi.org/10.3390/cancers14133164
APA Style
Bilemjian, V., Vlaming, M. R., Álvarez Freile, J., Huls, G., De Bruyn, M., & Bremer, E.
(2022). The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR Signaling. Cancers, 14(13), 3164.
https://doi.org/10.3390/cancers14133164